MyJournals Home  

RSS FeedsThe Mevalonate Pathway Is a Druggable Target for Vaccine Adjuvant Discovery (Cell)

 
 

29 september 2018 21:00:11

 
The Mevalonate Pathway Is a Druggable Target for Vaccine Adjuvant Discovery (Cell)
 


Lipophilic statins and bisphosphonates that target three enzymes in the mevalonate pathway have vaccine adjuvant activities in mice and monkeys and can synergize with anti-PD1 therapy.


 
56 viewsCategory: Cell Biology, General
 
TCR Transgenic Mice Reveal Stepwise, Multi-site Acquisition of the Distinctive Fat-Treg Phenotype (Cell)
Structural Remodeling of the Human Colonic Mesenchyme in Inflammatory Bowel Disease (Cell)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

General


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten